Next-Generation Sequencing (NGS) for Residual Disease (MRD) Monitoring in TLymphoblastic Leukemia (T-ALL)

被引：1
|
作者：
Roy, Ntasha [1 ]
Mao, Zhengwei [2 ]
Xu, Chang [2 ]
Teachey, David T. [3 ]
Chen, Zhiguo [4 ]
Devidas, Meenakshi [5 ]
Chen, Xueyan [6 ]
Raetz, Elizabeth A. [7 ]
Loh, Mignon L. [8 ]
Hunger, Stephen P. [9 ]
Wood, Brent L. [1 ,10 ]
机构：
[1] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA
[2] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[3] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA
[4] Univ Florida, Biostatist, Gainesville, FL USA
[5] St Jude Childrens Res Hosp, Memphis, TN USA
[6] Fred Hutchinson Canc Ctr, Seattle, WA USA
[7] Dept Pediat, NYU Langone Hlth, New York, NY USA
[8] Seattle Childrens Hosp, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA
[9] Childrens Hosp Philadelphia, Philadelphia, PA USA
[10] Univ Washington, Dept Lab Med, Seattle, WA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190624
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Alejandro Medina
    Noemi Puig
    Juan Flores-Montero
    Cristina Jimenez
    M.-Eugenia Sarasquete
    María Garcia-Alvarez
    Isabel Prieto-Conde
    Carmen Chillon
    Miguel Alcoceba
    Norma C. Gutierrez
    Albert Oriol
    Laura Rosinol
    Joan Bladè
    Mercedes Gironella
    Miguel T. Hernandez
    Veronica Gonzalez-Calle
    Maria-Teresa Cedena
    Bruno Paiva
    Jesus F. San-Miguel
    Juan-Jose Lahuerta
    Maria-Victoria Mateos
    Joaquin Martinez-Lopez
    Alberto Orfao
    Marcos Gonzalez
    Ramon Garcia-Sanz
    Blood Cancer Journal, 10
  • [2] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Medina, Alejandro
    Puig, Noemi
    Flores-Montero, Juan
    Jimenez, Cristina
    Sarasquete, M. -Eugenia
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gutierrez, Norma C.
    Oriol, Albert
    Rosinol, Laura
    Blade, Joan
    Gironella, Mercedes
    Hernandez, Miguel T.
    Gonzalez-Calle, Veronica
    Cedena, Maria-Teresa
    Paiva, Bruno
    San-Miguel, Jesus F.
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Orfao, Alberto
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [3] Development Of Minimal Residual Disease (MRD) Analysis In Childhood Acute Lymphoblastic Leukaemia (ALL) By Next Generation Sequencing (NGS)
    Williamson, Helen
    Mountjoy, Edward
    Shihab, Hashem
    Bartram, Jack
    Hubank, Mike
    Goulden, Nicholas
    Day, Ian
    Roberts, Eileen
    Moppett, John
    Hancock, Jeremy
    BLOOD, 2013, 122 (21)
  • [4] Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
    Michaela Kotrova
    Jan Trka
    Michael Kneba
    Monika Brüggemann
    Molecular Diagnosis & Therapy, 2017, 21 : 481 - 492
  • [5] Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
    Kotrova, Michaela
    Trka, Jan
    Kneba, Michael
    Brueggemann, Monika
    MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (05) : 481 - 492
  • [6] miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity
    Dawidowska, Malgorzata
    Szarzynska-Zawadzka, Bronislawa
    Jaksik, Roman
    Drobna, Monika
    Kosmalska, Maria
    Lukasz, Sedek
    Szczepanski, Tomasz
    Witt, Michal
    BLOOD, 2017, 130
  • [7] Prospective Evaluation of the Impact of Measurable Residual Disease (MRD) By Error Corrected Next-Generation Sequencing (NGS) with CPX-351 in Acute Myeloid Leukemia (AML)
    Sallman, David
    Mclemore, Amy F.
    Chan, Onyee
    Kuykendall, Andrew T.
    Padron, Eric
    Xie, Zhuoer
    Walker, Alison R.
    Spencer, David H.
    Komrokji, Rami S.
    Lancet, Jeffrey E.
    Jacoby, Meagan
    BLOOD, 2024, 144 : 4332 - 4333
  • [8] Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia
    Germano, Giuseppe
    Valsecchi, Maria Grazia
    Buldini, Barbara
    Cazzaniga, Giovanni
    Zanon, Carlo
    Silvestri, Daniela
    te Kronnie, Geertruij
    Basso, Giuseppe
    Paganin, Maddalena
    PEDIATRIC BLOOD & CANCER, 2020, 67 (01)
  • [9] Target-Capture Next-Generation Sequencing (NGS) for Use in Molecular-Based Research of Myeloid Measurable Residual Disease (MRD)
    Speight, G.
    Milner, N.
    Reid, J.
    Pullabhatla, V.
    Holdstock, J.
    Georgieva, L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S48 - S49
  • [10] Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel
    Duchstein, Lara
    Sloane, Hillary S.
    Fredebohm, Johannes
    Ryder, Matthew
    BLOOD, 2020, 136
12345